Analyst Research

Report Title Price
Provider: S&P Capital IQ Factual Report
Provider: Reuters Investment Profile
Provider: GlobalData
Provider: GlobalData

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

CytoDyn Inc Completes $14.5 Million Private Equity Offering

Thursday, 24 Oct 2013 07:40pm EDT 

CytoDyn Inc announced the completion of equity capital raise for a total of $14.5 million through a private offering. The proceeds from the offering will be used to fund current operating expenses in order to continue the development of the Company's primary drug candidate, PRO 140. 

Company Quote

1:00pm EST